GLENN SBLENDORIO - 09 Dec 2021 Form 4 Insider Report for IVERIC bio, Inc. (ISEE)

Role: Chief Executive Officer, Director
Signature: /s/ Todd Anderman, as Attorney-in-Fact for Glenn P. Sblendorio
Issuer symbol: ISEE
Transactions as of: 09 Dec 2021
Transactions value $: $0
Form type: 4
Filing time: 13 Dec 2021, 18:50:40 UTC
Previous filing: 14 Jun 2021
Next filing: 14 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ISEE	Common Stock	Options Exercise		+23.8K	+8.4%		306K	09 Dec 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ISEE	Restricted Stock Units	Options Exercise	$0	-23.8K	-33.33%	$0.00	47.5K	09 Dec 2021	Common Stock	23.8K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
F2	This total includes 6,249 shares acquired by the Reporting Person on September 16, 2019, 1,313 shares acquired by the Reporting Person on March 15, 2021, and 1,257 shares acquired by the Reporting Person on September 15, 2021, under the Registrant's 2016 Employee Stock Purchase Plan that were not previously reported.
F3	On December 9, 2019, the Reporting Person was granted an award of 95,000 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan.